Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Invested Capital (2019 - 2026)

BioScience Health Innovations has reported Invested Capital over the past 8 years, most recently at $1.7 million for Q1 2026.

  • Quarterly Invested Capital rose 33.47% to $1.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Mar 2026, up 33.47% year-over-year, with the annual reading at $1.5 million for FY2025, 76.87% up from the prior year.
  • Invested Capital was $1.7 million for Q1 2026 at BioScience Health Innovations, up from $1.5 million in the prior quarter.
  • Over five years, Invested Capital peaked at $1.7 million in Q2 2025 and troughed at -$88990.0 in Q1 2023.
  • The 5-year median for Invested Capital is $114859.0 (2024), against an average of $548746.2.
  • Year-over-year, Invested Capital tumbled 68.87% in 2022 and then skyrocketed 12455.62% in 2024.
  • A 5-year view of Invested Capital shows it stood at $25476.0 in 2022, then crashed by 126.53% to -$6760.0 in 2023, then skyrocketed by 12455.62% to $835240.0 in 2024, then skyrocketed by 76.87% to $1.5 million in 2025, then increased by 14.02% to $1.7 million in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Invested Capital are $1.7 million (Q1 2026), $1.5 million (Q4 2025), and $1.7 million (Q3 2025).